The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes ...

People have been showing off their before-and-after when taking Ozempic and other weight-loss ... found people who received weekly semaglutide injections lost an average of about 15 pounds after ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

The two studies conducted by University of Southern Denmark (SDU) found that Ozempic more than doubles the risk of NAION, or non-arteritic anterior ischemic optic neuropathy, for type 2 diabetes ...

Ozempic (semaglutide) is prescribed for adults with type 2 diabetes. The drug is given as an injection under the skin once per week. Doctors usually prescribe a starting dose and a maintenance dose.

Ozempic and the other class of new weight-loss drugs is upending how Americans live their lives as entire industries respond the the nation's shrinking waist-lines. K KStock - stock.adobe.com The ...

However, eight weeks ago, I started to use Ozempic injections. All the desire I normally feel for Jim has vanished along with the extra kilos. I'm feeling better about my body than I have in years ...

Amgen reported today the highly anticipated results of a mid-stage trial of its experimental weight loss drug and potential Ozempic competitor MariTide, however, Wall Street wasn’t very impressed.

Ozempic (semaglutide) and Trulicity (dulaglutide) are brand-name subcutaneous injections. They’re both prescribed for adults with type 2 diabetes who may or may not have certain cardiovascular ...

Losing face? Take heart. There’s a new supplement on the market that promises to put an end to the droopy aesthetic of “Ozempic face” — in addition to some of the other unpleasant side ...